Table of Contents 1 Prostate Cancer Nuclear Medicine Diagnostics Market Overview 1.1 Product Overview and Scope of Prostate Cancer Nuclear Medicine Diagnostics 1.2 Classification of Prostate Cancer Nuclear Medicine Diagnostics by Types 1.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Comparison by Types (2019-2024) 1.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Types in 2018 1.2.3 SPECT 1.2.4 PET 1.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market by Application 1.3.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Global Prostate Cancer Nuclear Medicine Diagnostics Market by Regions 1.4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Nuclear Medicine Diagnostics Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Nuclear Medicine Diagnostics Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Nuclear Medicine Diagnostics Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Nuclear Medicine Diagnostics Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Nuclear Medicine Diagnostics Status and Prospect (2014-2024) 1.5 Global Market Size of Prostate Cancer Nuclear Medicine Diagnostics (2014-2024) 2 Company Profiles 2.1 Blue Earth Diagnostics 2.1.1 Business Overview 2.1.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.2 Telix Pharma 2.2.1 Business Overview 2.2.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.3 Lantheus Medical Imaging 2.3.1 Business Overview 2.3.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.4 PETNET Solutions 2.4.1 Business Overview 2.4.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.5 Progenics Pharma 2.5.1 Business Overview 2.5.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.6 Cardinal Health 2.6.1 Business Overview 2.6.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.7 Theragnostics 2.7.1 Business Overview 2.7.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.8 NCM-USA 2.8.1 Business Overview 2.8.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.9 Jubilant Pharma 2.9.1 Business Overview 2.9.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.10 ImaginAb 2.10.1 Business Overview 2.10.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.11 Novartis 2.11.1 Business Overview 2.11.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 2.12 Alliance Medical 2.12.1 Business Overview 2.12.2 Prostate Cancer Nuclear Medicine Diagnostics Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) 3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Competition, by Players 3.1 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Prostate Cancer Nuclear Medicine Diagnostics Players Market Share 3.2.2 Top 10 Prostate Cancer Nuclear Medicine Diagnostics Players Market Share 3.3 Market Competition Trend 4 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Regions 4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue and Market Share by Regions 4.2 North America Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 4.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 4.5 South America Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 5 North America Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries 5.1 North America Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries (2014-2019) 5.2 USA Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 5.3 Canada Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 5.4 Mexico Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 6 Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries 6.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries (2014-2019) 6.2 Germany Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 6.3 UK Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 6.4 France Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 6.5 Russia Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 6.6 Italy Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries 7.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries (2014-2019) 7.2 China Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 7.3 Japan Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 7.4 Korea Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 7.5 India Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 8 South America Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries 8.1 South America Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries (2014-2019) 8.2 Brazil Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 8.3 Argentina Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 8.4 Colombia Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Prostate Cancer Nuclear Medicine Diagnostics by Countries 9.1 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries (2014-2019) 9.2 Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 9.3 UAE Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 9.4 Egypt Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 9.5 Nigeria Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 9.6 South Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) 10 Global Prostate Cancer Nuclear Medicine Diagnostics Market Segment by Type 10.1 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue and Market Share by Type (2014-2019) 10.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Type (2019-2024) 10.3 SPECT Revenue Growth Rate (2014-2024) 10.4 PET Revenue Growth Rate (2014-2024) 11 Global Prostate Cancer Nuclear Medicine Diagnostics Market Segment by Application 11.1 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Application (2014-2019) 11.2 Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Application (2019-2024) 11.3 Hospitals Revenue Growth (2014-2019) 11.4 Clinics Revenue Growth (2014-2019) 11.5 Others Revenue Growth (2014-2019) 12 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast (2019-2024) 12.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Forecast (2019-2024) 12.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Forecast by Regions (2019-2024) 12.3 North America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) 12.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) 12.6 South America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Prostate Cancer Nuclear Medicine Diagnostics Picture Table Product Specifications of Prostate Cancer Nuclear Medicine Diagnostics Table Global Prostate Cancer Nuclear Medicine Diagnostics and Revenue (Million USD) Market Split by Product Type Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Types in 2018 Figure SPECT Picture Figure PET Picture Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) by Application (2014-2024) Figure Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Applications in 2018 Figure Hospitals Picture Figure Clinics Picture Figure Others Picture Table Global Market Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) and Growth Rate (2014-2024) Table Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors Table Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Telix Pharma Basic Information, Manufacturing Base and Competitors Table Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors Table Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table PETNET Solutions Basic Information, Manufacturing Base and Competitors Table PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Progenics Pharma Basic Information, Manufacturing Base and Competitors Table Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Cardinal Health Basic Information, Manufacturing Base and Competitors Table Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Theragnostics Basic Information, Manufacturing Base and Competitors Table Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table NCM-USA Basic Information, Manufacturing Base and Competitors Table NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Jubilant Pharma Basic Information, Manufacturing Base and Competitors Table Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table ImaginAb Basic Information, Manufacturing Base and Competitors Table ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Novartis Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Alliance Medical Basic Information, Manufacturing Base and Competitors Table Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Type and Applications Table Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Revenue, Gross Margin and Market Share (2017-2018) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) by Players (2014-2019) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Players (2014-2019) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Players in 2017 Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Players in 2018 Figure Global Top 5 Players Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share in 2018 Figure Global Top 10 Players Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share in 2018 Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) by Regions (2014-2019) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Regions (2014-2019) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Regions (2014-2019) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Regions in 2018 Figure North America Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure South America Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Table North America Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries (2014-2019) Table North America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries (2014-2019) Figure North America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries (2014-2019) Figure North America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries in 2018 Figure USA Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Canada Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Mexico Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Table Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) by Countries (2014-2019) Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries (2014-2019) Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries in 2018 Figure Germany Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure UK Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure France Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Russia Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Italy Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Table Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries in 2018 Figure China Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Japan Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Korea Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure India Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Table South America Prostate Cancer Nuclear Medicine Diagnostics Revenue by Countries (2014-2019) Table South America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries (2014-2019) Figure South America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries (2014-2019) Figure South America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries in 2018 Figure Brazil Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Argentina Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Colombia Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Table Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Countries in 2018 Figure Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure UAE Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Egypt Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure Nigeria Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Figure South Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue and Growth Rate (2014-2019) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) by Type (2014-2019) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Type (2014-2019) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Type (2014-2019) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Type in 2018 Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Forecast by Type (2019-2024) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Market Share Forecast by Type (2019-2024) Figure Global SPECT Revenue Growth Rate (2014-2019) Figure Global PET Revenue Growth Rate (2014-2019) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Application (2014-2019) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Application (2014-2019) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Application (2014-2019) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Application in 2018 Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Forecast by Application (2019-2024) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Market Share Forecast by Application (2019-2024) Figure Global Hospitals Revenue Growth Rate (2014-2019) Figure Global Clinics Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Prostate Cancer Nuclear Medicine Diagnostics Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share Forecast by Regions (2019-2024) Figure North America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) Figure Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) Figure South America Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024) Figure Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Forecast (2019-2024)

Blue Earth Diagnostics Telix Pharma Lantheus Medical Imaging PETNET Solutions Progenics Pharma Cardinal Health Theragnostics NCM-USA Jubilant Pharma ImaginAb Novartis Alliance Medical